Pharmacological characterization of potent and selective NaV1.7 inhibitors engineered from Chilobrachys jingzhao tarantula venom peptide JzTx-V

Autor: John B. Jordan, Justin K. Murray, Kristin L. Andrews, Licheng Shi, Philippe Favreau, Ruoyuan Yin, Violeta Yu, Josie H. Lee, Kelvin K. C. Sham, Bin Wu, Kaustav Biswas, Dong Liu, Anruo Zou, Joseph Ligutti, Jason Long, Les P. Miranda, Bryan D. Moyer, Reto Stöcklin
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Male
0301 basic medicine
Science and Technology Workforce
Patch-Clamp Techniques
Physiology
Drug Evaluation
Preclinical

Action Potentials
Spider Venoms
lcsh:Medicine
Peptide
Toxicology
Pathology and Laboratory Medicine
Careers in Research
Protein Engineering
Nerve Fibers
Animal Cells
Ganglia
Spinal

Medicine and Health Sciences
Toxins
Macromolecular Engineering
lcsh:Science
Neurons
chemistry.chemical_classification
Analgesics
Multidisciplinary
Peptide analog
biology
Chemistry
NAV1.7 Voltage-Gated Sodium Channel
Recombinant Proteins
Cell biology
Peptide Conformation
Electrophysiology
Professions
Engineering and Technology
Synthetic Biology
Cellular Types
Research Article
Biotechnology
Sodium Channel Blockers
Cell Binding
Cell Physiology
Science Policy
Toxic Agents
Neurophysiology
Bioengineering
Tetrodotoxin
Inhibitory postsynaptic potential
Membrane Potential
Cell Line
Chilobrachys jingzhao
Structure-Activity Relationship
03 medical and health sciences
Physical Stimulation
Animals
Humans
Patch clamp
Binding site
Nuclear Magnetic Resonance
Biomolecular

Nerve Fibers
Unmyelinated

Venoms
Sodium channel
lcsh:R
Biology and Life Sciences
Engineers
Cell Biology
biology.organism_classification
Mice
Inbred C57BL

030104 developmental biology
Amino Acid Substitution
Synthetic Bioengineering
Cellular Neuroscience
People and Places
Mutagenesis
Site-Directed

Population Groupings
lcsh:Q
Capsaicin
Peptides
Neuroscience
Zdroj: PLoS ONE, Vol 13, Iss 5, p e0196791 (2018)
PLoS ONE
ISSN: 1932-6203
Popis: Identification of voltage-gated sodium channel NaV1.7 inhibitors for chronic pain therapeutic development is an area of vigorous pursuit. In an effort to identify more potent leads compared to our previously reported GpTx-1 peptide series, electrophysiology screening of fractionated tarantula venom discovered the NaV1.7 inhibitory peptide JzTx-V from the Chinese earth tiger tarantula Chilobrachys jingzhao. The parent peptide displayed nominal selectivity over the skeletal muscle NaV1.4 channel. Attribute-based positional scan analoging identified a key Ile28Glu mutation that improved NaV1.4 selectivity over 100-fold, and further optimization yielded the potent and selective peptide leads AM-8145 and AM-0422. NMR analyses revealed that the Ile28Glu substitution changed peptide conformation, pointing to a structural rationale for the selectivity gains. AM-8145 and AM-0422 as well as GpTx-1 and HwTx-IV competed for ProTx-II binding in HEK293 cells expressing human NaV1.7, suggesting that these NaV1.7 inhibitory peptides interact with a similar binding site. AM-8145 potently blocked native tetrodotoxin-sensitive (TTX-S) channels in mouse dorsal root ganglia (DRG) neurons, exhibited 30- to 120-fold selectivity over other human TTX-S channels and exhibited over 1,000-fold selectivity over other human tetrodotoxin-resistant (TTX-R) channels. Leveraging NaV1.7-NaV1.5 chimeras containing various voltage-sensor and pore regions, AM-8145 mapped to the second voltage-sensor domain of NaV1.7. AM-0422, but not the inactive peptide analog AM-8374, dose-dependently blocked capsaicin-induced DRG neuron action potential firing using a multi-electrode array readout and mechanically-induced C-fiber spiking in a saphenous skin-nerve preparation. Collectively, AM-8145 and AM-0422 represent potent, new engineered NaV1.7 inhibitory peptides derived from the JzTx-V scaffold with improved NaV selectivity and biological activity in blocking action potential firing in both DRG neurons and C-fibers.
Databáze: OpenAIRE